Monosialotetrahexosylganglioside sodium
Indication
Used to treat vascular or traumatic central nervous system injury and Parkinson's disease.
Precautions
It is contraindicated for patients who are allergic to this product or have hereditary abnormal glucose and lipid metabolism (ganglioside storage disease, such as familial tay-sachs dementia, retinal degeneration).
Manufacturer
Jilin Yinglian Biopharmaceutical Co., Ltd.
-
Founded in:
2002-07-19 -
Address:
No. 1188, Renmin West Road, Panshi Economic Development Zone, Jilin -
Tax NO.:
91220000735934496U -
Registered Funds:
45 million yuan -
Email: